11.65 USD
-0.58 (-4.74%)
11.75 USD
+0.1 (+0.86%)
ChartMill assigns a Buy % Consensus number of 87% to BNTC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 28.22. This target is 142.23% above the current price.
BNTC was analyzed by 14 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about BNTC.
In the previous month the buy percentage consensus was at a similar level.
BNTC was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-04 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-04 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-24 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-09-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-10 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-03-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-18 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-13 | Baird | Initiate | Outperform |
| 2024-12-03 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-10-16 | Oppenheimer | Initiate | Outperform |
| 2024-10-14 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-09-30 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-09-12 | Guggenheim | Initiate | Buy |
| 2024-07-22 | Leerink Partners | Initiate | Outperform |
| 2024-06-13 | Piper Sandler | Initiate | Overweight |
| 2024-04-22 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-02-15 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-01-24 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-09-26 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-06-26 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2023-05-18 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2022-10-18 | JMP Securities | Initiate | Market Outperform |
| 2022-09-23 | HC Wainwright & Co. | Maintains | Buy |
| 2022-02-17 | HC Wainwright & Co. | Initiate | Buy |
BENITEC BIOPHARMA INC / BNTC FAQ
What is the price target for BNTC stock?
14 analysts have analysed BNTC and the average price target is 28.22 USD. This implies a price increase of 142.23% is expected in the next year compared to the current price of 11.65.
Can you provide the consensus rating for BENITEC BIOPHARMA INC stock?
The consensus rating for BENITEC BIOPHARMA INC (BNTC) is 87.1429 / 100 . This indicates that analysts generally have a positive outlook on the stock.